Hydrogen peroxide impairs autophagic flux in a cell model of nonalcoholic fatty liver disease

Biochemical and Biophysical Research Communications

Volumn 433, Issue 4, 2013, Pages 408-414

  Jiang, Pengtao ^a,c   Huang, Zhen ^b   Zhao, Hong ^b   Wei, Taotao ^a  

^a INSTITUTE OF BIOPHYSICS   (China)

^b CANCER HOSPITAL   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Autophagy; Nonalcoholic fatty liver disease; Reactive oxygen species; TNF

Indexed keywords

FATTY ACID; HYDROGEN PEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CONTROLLED STUDY; HEPATOMA CELL; HUMAN; HUMAN CELL; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RAT;

ANIMALS; AUTOPHAGY; CELL SURVIVAL; FATTY ACIDS, NONESTERIFIED; FATTY LIVER; HEP G2 CELLS; HUMANS; HYDROGEN PEROXIDE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYSOSOMES; MODELS, BIOLOGICAL; OXIDATIVE STRESS; PHAGOSOMES; PROTEIN-SERINE-THREONINE KINASES; RATS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84876459715     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.02.118     Document Type: Article

References (25)

1. Marchesini G., Brizi M., Bianchi G., Tomassetti S., Bugianesi E., Lenzi M., McCullough A.J., Natale S., Forlani G., Melchionda N. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001, 50:1844-1850.
2. Mendez-Sanchez N., Arrese M., Zamora-Valdes D., Uribe M. Current concepts in the pathogenesis of nonalcoholic fatty liver disease. Liver Int. 2007, 27:423-433.
3. Kumashiro N., Erion D.M., Zhang D., Kahn M., Beddow S.A., Chu X., Still C.D., Gerhard G.S., Han X., Dziura J., Petersen K.F., Samuel V.T., Shulman G.I. Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc. Natl. Acad. Sci. USA 2011, 108:16381-16385.
4. Browning J.D., Szczepaniak L.S., Dobbins R., Nuremberg P., Horton J.D., Cohen J.C., Grundy S.M., Hobbs H.H. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004, 40:1387-1395.
5. Fan J.G., Farrell G.C. Epidemiology of non-alcoholic fatty liver disease in China. J. Hepatol. 2009, 50:204-210.
6. Charlton M. Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clin. Gastroenterol. Hepatol. 2004, 2:1048-1058.
7. Grant L.M., Lisker-Melman M. Nonalcoholic fatty liver disease. Ann. Hepatol. 2004, 3:93-99.
8. Clark J.M., Brancati F.L., Diehl A.M. Nonalcoholic fatty liver disease. Gastroenterology 2002, 122:1649-1657.
9. Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008, 132:27-42.
10. Rubinsztein D.C., Gestwicki J.E., Murphy L.O., Klionsky D.J. Potential therapeutic applications of autophagy. Nat. Rev. Drug Discovery 2007, 6:304-312.
11. Levine B. Cell biology: autophagy and cancer. Nature 2007, 446:745-747.
12. Amir M., Czaja M.J. Autophagy in nonalcoholic steatohepatitis. Expert Rev. Gastroenterol. Hepatol. 2011, 5:159-166.
13. Day C.P., James O.F. Steatohepatitis: a tale of two "hits"?. Gastroenterology 1998, 114:842-845.
14. Dowman J.K., Tomlinson J.W., Newsome P.N. Pathogenesis of non-alcoholic fatty liver disease. Q. J. Med. 2010, 103:71-83.
15. Huang J., Lam G.Y., Brumell J.H. Autophagy signaling through reactive oxygen species. Antioxid. Redox Signaling 2011, 14:2215-2231.
16. Zhou R., Yazdi A.S., Menu P., Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011, 469:221-225.
17. Ashkenazi A., Herbst R.S. To kill a tumor cell: the potential of proapoptotic receptor agonists. J. Clin. Invest. 2008, 118:1979-1990.
18. Djavaheri-Mergny M., Maiuri M.C., Kroemer G. Cross talk between apoptosis and autophagy by caspase-mediated cleavage of Beclin 1. Oncogene 2010, 29:1717-1719.
19. Jia G., Cheng G., Gangahar D.M., Agrawal D.K. Insulin-like growth factor-1 and TNF-alpha regulate autophagy through c-jun N-terminal kinase and Akt pathways in human atherosclerotic vascular smooth cells. Immunol. Cell Biol. 2006, 84:448-454.
20. Feldstein A.E., Werneburg N.W., Canbay A., Guicciardi M.E., Bronk S.F., Rydzewski R., Burgart L.J., Gores G.J. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 2004, 40:185-194.
21. Oliveira C.P., da Costa Gayotto L.C., Tatai C., Della Bina B.I., Janiszewski M., Lima E.S., Abdalla D.S., Lopasso F.P., Laurindo F.R., Laudanna A.A. Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet. J. Cell Mol. Med. 2002, 6:399-406.
22. Alers S., Loffler A.S., Wesselborg S., Stork B. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Mol. Cell Biol. 2012, 32:2-11.
23. Kim J., Kundu M., Viollet B., Guan K.L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 2011, 13:132-141.
24. Baehrecke E.H. Autophagy: dual roles in life and death?. Nat. Rev. Mol. Cell Biol. 2005, 6:505-510.
25. Gump J.M., Thorburn A. Autophagy and apoptosis: what is the connection?. Trends Cell Biol. 2011, 21:387-392.